Legal Representation
Attorney
SUSAN E COLMAN
USPTO Deadlines
Next Deadline
1889 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250401)
Due Date
April 01, 2031
Grace Period Ends
October 01, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 19, 2025 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Dec 19, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Dec 19, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Dec 19, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Dec 19, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Apr 1, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 1, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Feb 11, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Feb 11, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Feb 5, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Jan 17, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Jan 17, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Jan 17, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 17, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Jan 17, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Jan 16, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 30, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Oct 30, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Promoting public awareness of the interests of patients and caregivers in the rare disease community by collecting information and issuing a large-scale study tracking the evolving experiences of those impacted by rare diseases, with the purpose of shaping medical care, informing national and local policy decisions, and supporting increased access to resources to improve quality of life
First Use Anywhere:
Oct 18, 2024
First Use in Commerce:
Oct 18, 2024
Classification
International Classes
035
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"STUDY"